TY - JOUR
T1 - Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice
AU - Brunskill, Eric W.
AU - Ehrman, Lisa A.
AU - Williams, Michael T.
AU - Klanke, Justin
AU - Hammer, Daniel
AU - Schaefer, Tori L.
AU - Sah, Renu
AU - Dorn, Gerald W.
AU - Potter, S. Steven
AU - Vorhees, Charles V.
PY - 2005/9
Y1 - 2005/9
N2 - Npas3 is a member of the bHLH-PAS superfamily of transcription factors that is expressed broadly in the developing neuroepithelium. To study the function of this gene, mice deficient in Npas3 were generated and characterized. Npas3-/- mice were growth-retarded and exhibited developmental brain abnormalities that included a reduction in size of the anterior hippocampus, hypoplasia of the corpus callosum and enlargement of the ventricles. A number of behavioural abnormalities were identified in Npas3-/- mice including locomotor hyperactivity, subtle gait defects, impairment of prepulse inhibition of acoustic startle, deficit in recognition memory and altered anxiety-related responses. Characterization of neurosignaling pathways using several pharmacological agents revealed dysfunctional glutamate, dopamine and serotonin neurotransmitter signaling. Consistent with these findings, we identified a significant alteration in cortical PSD-95 expression, a PDZ-containing protein that has been shown to be involved in postsynaptic signal transduction. Together, our observations indicate an important role for Npas3 in controlling normal brain development and neurosignaling pathways.
AB - Npas3 is a member of the bHLH-PAS superfamily of transcription factors that is expressed broadly in the developing neuroepithelium. To study the function of this gene, mice deficient in Npas3 were generated and characterized. Npas3-/- mice were growth-retarded and exhibited developmental brain abnormalities that included a reduction in size of the anterior hippocampus, hypoplasia of the corpus callosum and enlargement of the ventricles. A number of behavioural abnormalities were identified in Npas3-/- mice including locomotor hyperactivity, subtle gait defects, impairment of prepulse inhibition of acoustic startle, deficit in recognition memory and altered anxiety-related responses. Characterization of neurosignaling pathways using several pharmacological agents revealed dysfunctional glutamate, dopamine and serotonin neurotransmitter signaling. Consistent with these findings, we identified a significant alteration in cortical PSD-95 expression, a PDZ-containing protein that has been shown to be involved in postsynaptic signal transduction. Together, our observations indicate an important role for Npas3 in controlling normal brain development and neurosignaling pathways.
KW - Behavioural abnormalities
KW - Brain development
KW - Developing neuroepithelium
KW - Developmental abnormalities
KW - PSD-95
KW - bHLH-PAS
UR - http://www.scopus.com/inward/record.url?scp=26644440895&partnerID=8YFLogxK
U2 - 10.1111/j.1460-9568.2005.04291.x
DO - 10.1111/j.1460-9568.2005.04291.x
M3 - Article
C2 - 16190882
AN - SCOPUS:26644440895
SN - 0953-816X
VL - 22
SP - 1265
EP - 1276
JO - European Journal of Neuroscience
JF - European Journal of Neuroscience
IS - 6
ER -